{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:58:30Z","timestamp":1769875110811,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","award":["16346-SAL-44"],"award-info":[{"award-number":["16346-SAL-44"]}],"id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","award":["PRIN2008"],"award-info":[{"award-number":["PRIN2008"]}],"id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005389","name":"Universit\u00e0 degli Studi dell'Insubria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.neuropharm.2014.03.015","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T15:54:41Z","timestamp":1396972481000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood"],"prefix":"10.1016","volume":"83","author":[{"given":"Quentin","family":"Rainer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Speziali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Dominguez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis Rodriguez","family":"Bambico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4124-9825","authenticated-orcid":false,"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Parolaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.03.015_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1601-183X.2008.00458.x","article-title":"Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice","volume":"8","author":"Ambar","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.coph.2004.05.006","article-title":"Abuse of anabolic androgenic steroids and related substances in sport and exercise","volume":"4","author":"Bahrke","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00007256-200029060-00003","article-title":"Risk factors associated with anabolic-androgenic steroid use among adolescents","volume":"29","author":"Bahrke","year":"2000","journal-title":"Sports Med."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.euroneuro.2008.11.005","article-title":"Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress","volume":"19","author":"Bambico","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nbd.2009.11.020","article-title":"Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission","volume":"37","author":"Bambico","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0028-3908(80)90187-2","article-title":"Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists","volume":"19","author":"Baraban","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1460-9568.2005.03942.x","article-title":"19-Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain","volume":"21","author":"Brannvall","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuropharm.2005.11.017","article-title":"Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence","volume":"50","author":"Celerier","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0306-4522(94)00532-A","article-title":"Regional changes in c-fos expression in the basal forebrain and brainstem during adaptation to repeated stress: correlations with cardiovascular, hypothermic and endocrine responses","volume":"64","author":"Chen","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainres.2006.08.081","article-title":"Sex- and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions","volume":"1126","author":"Clark","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1037\/0735-7044.110.6.1478","article-title":"Comparison of the effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the sexual behavior of castrated male rats","volume":"110","author":"Clark","year":"1996","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.psyneuen.2010.04.015","article-title":"Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse","volume":"35","author":"Costine","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/rp.56.1.309","article-title":"The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis","volume":"56","author":"Collins","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib16","first-page":"81","article-title":"Androgenic-anabolic steroids abuse in males","volume":"28","author":"Di Luigi","year":"2005","journal-title":"J.\u00a0Endocrinol. Investig."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1515\/revneuro-2012-0044","article-title":"Characterization of serotonin neurotransmission in knockout mice: implications for major depression","volume":"23","author":"Dominguez-Lopez","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-003-0633-z","article-title":"The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology","volume":"59","author":"Ekl\u00f6f","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0896-6273(00)81084-3","article-title":"From lesions to leptin: hypothalamic control of food intake and body weight","volume":"22","author":"Elmquist","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1471-4159.1997.69010144.x","article-title":"Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress","volume":"69","author":"Finlay","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3565(24)38843-3","article-title":"Modifications of the serotonergic system in mice lacking serotonin transporters: an in\u00a0vivo electrophysiological study","volume":"296","author":"Gobbi","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib24","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib25","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1523\/JNEUROSCI.04-11-02877.1984","article-title":"The control of firing pattern in nigral dopamine neurons: burst firing","volume":"4","author":"Grace","year":"1984","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0091-3057(02)00880-8","article-title":"Serotonin modulates offensive attack in adolescent anabolic steroid-treated hamsters","volume":"73","author":"Grimes","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1037\/0735-7044.119.5.1184","article-title":"Serotonin-1B receptor activity and expression modulate the aggression-stimulating effects of adolescent anabolic steroid exposure in hamsters","volume":"119","author":"Grimes","year":"2005","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000012362","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use in women","volume":"69","author":"Gruber","year":"2000","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.neuroscience.2004.06.006","article-title":"Distribution of androgen receptor immunoreactivity in the brainstem of male rats","volume":"127","author":"Hamson","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib30","first-page":"178","article-title":"Androgen interaction through multiple steroid receptors","volume":"102","author":"Janne","year":"1990","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/eurpub\/11.3.322","article-title":"Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects","volume":"11","author":"Kindlundh","year":"2001","journal-title":"Eur. J. Pub. Health"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4522(03)00120-9","article-title":"The anabolic-androgenic steroid nandrolone induces alterations in the density of serotonergic 5HT1B and 5HT2 receptors in the male rat brain","volume":"119","author":"Kindlundh","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1017\/S1461145708008754","article-title":"Nandrolone abuse decreases anxiety and impairs memory in rats via central androgenic receptors","volume":"11","author":"Kouvelas","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2005.02.071","article-title":"The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats","volume":"1044","author":"Kurling","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/S1461145711001544","article-title":"Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood","volume":"15","author":"Labonte","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0006-8993(03)03223-2","article-title":"Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels","volume":"986","author":"Lindblom","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0166-4328(01)00408-9","article-title":"Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels","volume":"133","author":"Lindqvist","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.physbeh.2010.01.007","article-title":"Impact of anabolic androgenic steroids on adolescent males","volume":"100","author":"Lumia","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00042752-199501000-00005","article-title":"Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users","volume":"5","author":"Malone","year":"1995","journal-title":"Clin. J. Sport Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2014.03.015_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neuropharm.2010.01.015","article-title":"Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior","volume":"58","author":"Matrisciano","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-3057(93)90031-N","article-title":"Behavioral effects of long-term administration of an anabolic steroid in intact and castrated male Wistar rats","volume":"44","author":"Minkin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib43","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/npp.2011.334","article-title":"Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse","volume":"37","author":"Oberlander","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib44","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrn2513","article-title":"Why do many psychiatric disorders emerge during adolescence?","volume":"9","author":"Paus","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib45","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib46","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1523\/JNEUROSCI.3108-09.2009","article-title":"Chronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor- and estrogen receptor-mediated mechanisms","volume":"29","author":"Penatti","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1520\/JFS2002240","article-title":"Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use","volume":"48","author":"Perry","year":"2003","journal-title":"J.\u00a0Forensic. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2014.03.015_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006842-199707000-00015","article-title":"Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans","volume":"59","author":"Pike","year":"1997","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1176\/ajp.145.4.487","article-title":"Affective and psychotic symptoms associated with anabolic steroid use","volume":"145","author":"Pope","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes","volume":"51","author":"Pope","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/mol.111.075796","article-title":"Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety\/depression based on repeated corticosterone administration","volume":"81","author":"Rainer","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2010.09.003","article-title":"Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats","volume":"60","author":"Realini","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.yhbeh.2012.09.007","article-title":"Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters","volume":"62","author":"Ricci","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2006.06.022","article-title":"Serotonin-1A receptor activity and expression modulate adolescent anabolic\/androgenic steroid-induced aggression in hamsters","volume":"85","author":"Ricci","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2826.2005.01292.x","article-title":"Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats","volume":"17","author":"Robichaud","year":"2005","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/10253890701281344","article-title":"Influence of anabolic steroid on anxiety levels in sedentary male rats","volume":"10","author":"Rocha","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0100-879X1997000300002","article-title":"Animal models of anxiety: an ethological perspective","volume":"30","author":"Rodgers","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib58","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/sj.npp.1301664","article-title":"Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates","volume":"33","author":"Rubino","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neures.2004.02.011","article-title":"Expression of estrogen receptors (alpha, beta) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences","volume":"49","author":"Sheng","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib61","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/S0140-6736(08)60801-6","article-title":"Use of doping agents, particularly anabolic steroids, in sports and society","volume":"371","author":"Sjoqvist","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(01)03121-3","article-title":"Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons","volume":"922","author":"Szabo","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/jpet.102.033282","article-title":"Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons","volume":"302","author":"Szabo","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005768-200301000-00006","article-title":"Nandrolone decanoate enhances hypothalamic biogenic amines in rats","volume":"35","author":"Tamaki","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10401239909147074","article-title":"Anabolic androgenic steroids and suicide","volume":"11","author":"Thiblin","year":"1999","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00023210-200519070-00002","article-title":"Behavioural manifestations of anabolic steroid use","volume":"19","author":"Trenton","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2014.03.015_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yrtph.2010.02.001","article-title":"Adverse health effects of anabolic-androgenic steroids","volume":"57","author":"van Amsterdam","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib69","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1530\/acta.0.109S0038","article-title":"Implications of basic pharmacology in the therapy with esters of nandrolone","volume":"271","author":"van der Vies","year":"1985","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.neuropharm.2014.03.015_bib70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2826.2011.02231.x","article-title":"Changes in oestrogen receptor-\u03b2 mRNA expression in male rat brain with age","volume":"24","author":"Yamaguchi","year":"2012","journal-title":"J.\u00a0Neuroendocrinol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:15:22Z","timestamp":1746177322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":69,"alternative-id":["S0028390814001208"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}